Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Antirheumatics/colchicine

Various toxicitites: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Feng J, et al. Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still's disease. Rheumatology Advances in Practice 7: No. 2, et al. May 2023. Available from: URL: http://doi.org/10.1093/rap/rkad046 Feng J, et al. Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still's disease. Rheumatology Advances in Practice 7: No. 2, et al. May 2023. Available from: URL: http://​doi.​org/​10.​1093/​rap/​rkad046
Metadaten
Titel
Antirheumatics/colchicine
Various toxicitites: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-43518-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Denosumab